Diabetic Ketoacidosis (DKA) Stepwise Management
DKA management requires early stabilization with isotonic IV fluids, continuous IV insulin, aggressive electrolyte replacement with close laboratory monitoring, and treatment of precipitating causes. 2025 ADA Inpatient Standards of Care—Diabetes Care in the Hospital
For adults, guideline-based care uses IV insulin with transition to subcutaneous insulin once resolution criteria are met. 2025 ADA Inpatient Standards of Care—DKA/HHS
Initial Diagnosis and Severity Stratification
DKA is defined by metabolic acidosis with ketosis, typically in the setting of hyperglycemia. [1]
Baseline evaluation should include measurement of glucose, electrolytes (including potassium), renal function, serum/urine ketones or beta-hydroxybutyrate, anion gap, and venous (or arterial) pH. 2025 ADA Inpatient Standards of Care—DKA/HHS
Laboratory targets used during therapy
- Resolution requires improvement of acidosis and closure of the anion gap. 2025 ADA Inpatient Standards of Care—DKA/HHS
- Transition planning should occur after sustained improvement in acidosis and anion gap closure. 2025 ADA Inpatient Standards of Care—DKA/HHS
Immediate Supportive Measures
Airway, breathing, and circulation should be stabilized early. 2025 ADA Inpatient Standards of Care—DKA/HHS
Continuous physiologic monitoring is recommended during IV insulin therapy. 2025 ADA Inpatient Standards of Care—DKA/HHS
Precipitating factors should be identified and treated during the same encounter (including infection, myocardial ischemia, missed insulin doses, and medication effects). 2025 ADA Inpatient Standards of Care—DKA/HHS
Fluid Resuscitation Strategy
Initial resuscitation should use isotonic crystalloid (e.g., 0.9% saline) to restore circulating volume. Hyperglycemic Crises in Adults With Diabetes: A Consensus Report (ADA)
Initial IV fluids are typically administered at about 1–1.5 L during the first 1–2 hours (institutional protocols may vary). [2]
As the glucose declines, IV dextrose should be added to maintain safe blood glucose while insulin continues to clear ketones. Hyperglycemic Crises in Adults With Diabetes: A Consensus Report (ADA)
IV Insulin Infusion Management
Continuous IV insulin infusion is recommended for DKA unless a specific alternative protocol is being used for selected uncomplicated cases. 2025 ADA Inpatient Standards of Care—DKA/HHS
Insulin should be started after confirmation that potassium is safe for insulin initiation. Management of Hyperglycemic Crises in Patients With Diabetes (older ADA consensus, potassium safety)
Insulin infusion should be titrated to maintain glucose around ~200 mg/dL (~11.1 mmol/L) while ketoacidosis resolves. Hyperglycemic Crises in Adults With Diabetes: A Consensus Report (ADA)
DKA treatment should continue until ketoacidosis is resolved and anion gap closure is achieved. 2025 ADA Inpatient Standards of Care—DKA/HHS
Potassium Replacement and Electrolyte Correction
Potassium replacement should be guided by serum potassium level because insulin drives potassium intracellularly. Management of Hyperglycemic Crises in Patients With Diabetes (older ADA consensus, hypokalemia safety)
Insulin should be delayed until serum potassium is >3.3 mEq/L if initial potassium is low to avoid arrhythmias. Management of Hyperglycemic Crises in Patients With Diabetes (older ADA consensus, K+ threshold)
Bicarbonate therapy is associated with additional risk of hypokalemia and should be used only when indicated by pH severity. [3]
Bicarbonate Indications
Bicarbonate is not routinely indicated for DKA. [3]
Bicarbonate is recommended for severe acidemia, typically when pH is <6.9 in ADA-based guidance summaries. [3]
Monitoring Frequency During Treatment
Electrolytes, renal function, glucose, and acid-base status should be monitored frequently during IV therapy to guide insulin and electrolyte replacement. Hyperglycemic Crises in Adults With Diabetes: A Consensus Report (ADA)
When clinical status stabilizes and resolution criteria are met, monitoring frequency can be reduced based on institutional protocol. 2025 ADA Inpatient Standards of Care—DKA/HHS
Transition From IV Insulin to Subcutaneous Insulin
Subcutaneous insulin should be initiated before stopping the IV infusion to prevent rebound hyperglycemia and ketosis. Hyperglycemic Crises in Adults With Diabetes: A Consensus Report (ADA)
An overlap of 1–2 hours between subcutaneous insulin administration and discontinuation of the IV insulin infusion is recommended. Hyperglycemic Crises in Adults With Diabetes: A Consensus Report (ADA)
The IV insulin infusion should be continued until ketoacidosis is resolved and transition is safely established with subcutaneous therapy. 2025 ADA Inpatient Standards of Care—DKA/HHS
Common Pitfalls to Avoid
Insulin should not be started when potassium is unsafe, due to risk of life-threatening hypokalemia during insulin therapy. Management of Hyperglycemic Crises in Patients With Diabetes (older ADA consensus, potassium safety)
Bicarbonate use should be restricted to severe acidemia because routine administration increases risk of complications such as hypokalemia. [3]
Stopping IV insulin without overlap after starting subcutaneous insulin increases risk of recurrent ketosis. Hyperglycemic Crises in Adults With Diabetes: A Consensus Report (ADA)
Practical Resolution Goals
Clinical and biochemical improvement should include closure of the anion gap and correction of acidosis. 2025 ADA Inpatient Standards of Care—DKA/HHS
Insulin infusion should be titrated to maintain glucose around ~200 mg/dL (~11.1 mmol/L) while continuing until ketoacidosis resolves. Hyperglycemic Crises in Adults With Diabetes: A Consensus Report (ADA)
Transition to maintenance subcutaneous insulin should be completed with appropriate overlap and continued monitoring until stability is confirmed. 2025 ADA Inpatient Standards of Care—DKA/HHS